Insufficient scRNA-seq data for expression of KDM8 at single-cell level.
Insufficient scRNA-seq data for expression of KDM8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 343.35 | 258 / 258 | 100% | 4.22 | 230 / 230 |
prostate | 100% | 395.99 | 245 / 245 | 100% | 6.48 | 502 / 502 |
thymus | 100% | 350.38 | 653 / 653 | 100% | 5.67 | 604 / 605 |
brain | 100% | 311.72 | 2632 / 2642 | 100% | 4.84 | 705 / 705 |
kidney | 100% | 251.89 | 89 / 89 | 100% | 3.79 | 897 / 901 |
liver | 100% | 3883.62 | 226 / 226 | 100% | 10.92 | 404 / 406 |
pancreas | 100% | 274.45 | 328 / 328 | 99% | 3.67 | 177 / 178 |
intestine | 100% | 325.36 | 966 / 966 | 99% | 3.04 | 523 / 527 |
breast | 100% | 246.85 | 459 / 459 | 99% | 4.16 | 1105 / 1118 |
bladder | 100% | 283.33 | 21 / 21 | 99% | 3.21 | 497 / 504 |
uterus | 100% | 337.04 | 170 / 170 | 98% | 3.97 | 452 / 459 |
skin | 99% | 174.98 | 1796 / 1809 | 99% | 3.35 | 468 / 472 |
lung | 99% | 240.93 | 575 / 578 | 99% | 2.92 | 1141 / 1155 |
stomach | 99% | 212.18 | 357 / 359 | 98% | 2.81 | 280 / 286 |
esophagus | 99% | 207.69 | 1436 / 1445 | 97% | 2.30 | 177 / 183 |
ovary | 100% | 298.06 | 180 / 180 | 94% | 2.41 | 403 / 430 |
eye | 0% | 0 | 0 / 0 | 100% | 6.34 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.72 | 29 / 29 |
spleen | 100% | 463.35 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.39 | 1 / 1 |
adipose | 100% | 215.02 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 184.44 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 187.80 | 793 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 4.03 | 44 / 45 |
heart | 97% | 139.69 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 171.96 | 860 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001701 | Biological process | in utero embryonic development |
GO_0031648 | Biological process | protein destabilization |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006508 | Biological process | proteolysis |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0048144 | Biological process | fibroblast proliferation |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0106157 | Molecular function | peptidyl-arginine 3-dioxygenase activity |
GO_0002039 | Molecular function | p53 binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0004177 | Molecular function | aminopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0051864 | Molecular function | histone H3K36 demethylase activity |
Gene name | KDM8 |
Protein name | Lysine demethylase 8 Bifunctional peptidase and arginyl-hydroxylase JMJD5 (EC 1.14.11.73) (EC 3.4.-.-) (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8) |
Synonyms | JMJD5 |
Description | FUNCTION: Bifunctional enzyme that acts both as an endopeptidase and 2-oxoglutarate-dependent monooxygenase . Endopeptidase that cleaves histones N-terminal tails at the carboxyl side of methylated arginine or lysine residues, to generate 'tailless nucleosomes', which may trigger transcription elongation . Preferentially recognizes and cleaves monomethylated and dimethylated arginine residues of histones H2, H3 and H4. After initial cleavage, continues to digest histones tails via its aminopeptidase activity . Upon DNA damage, cleaves the N-terminal tail of histone H3 at monomethylated lysine residues, preferably at monomethylated 'Lys-9' (H3K9me1). The histone variant H3F3A is the major target for cleavage . Additionally, acts as a Fe(2+) and 2-oxoglutarate-dependent monooxygenase, catalyzing (R)-stereospecific hydroxylation at C-3 of 'Arg-137' of RPS6 and 'Arg-141' of RCCD1, but the biological significance of this activity remains to be established . Regulates mitosis through different mechanisms: Plays a role in transcriptional repression of satellite repeats, possibly by regulating H3K36 methylation levels in centromeric regions together with RCCD1. Possibly together with RCCD1, is involved in proper mitotic spindle organization and chromosome segregation . Negatively regulates cell cycle repressor CDKN1A/p21, which controls G1/S phase transition . Required for G2/M phase cell cycle progression. Regulates expression of CCNA1/cyclin-A1, leading to cancer cell proliferation . Also, plays a role in regulating alpha-tubulin acetylation and cytoskeletal microtubule stability involved in epithelial to mesenchymal transition . Regulates the circadian gene expression in the liver (By similarity). Represses the transcriptional activator activity of the CLOCK-BMAL1 heterodimer in a catalytically-independent manner . Negatively regulates the protein stability and function of CRY1; required for AMPK-FBXL3-induced CRY1 degradation . . |
Accessions | ENST00000286096.9 [Q8N371-1] ENST00000441782.6 [Q8N371-3] ENST00000569329.1 H3BM39 ENST00000567735.1 H3BPT5 ENST00000562733.1 H3BR76 ENST00000568965.1 [Q8N371-2] Q8N371 |